Table 3. Descriptive statistics and comparison results of CA15-3 protein in M (metastasis), stage, prognostic stage, hormone type, and multifocal tumor subgroups.
c: Kruskal-Wallis H test<br>d: Mann-Whitney U test<br>*: 1B-4 are different from each other.<br>**: Luminal a - Luminal b her2+ are different from each other<br>Descriptive statistics median (shown as 25th–75th percentile)<br>χ2/ U: Test statistic
| Gruops | CA15-3 | χ2 / U | P |
|---|---|---|---|
| M<br>Distant metastasis (-) (n=67)<br>Distant metastasis (+) (n=11) | <br>17.78 (13.94–24.27)<br>27.30 (19.10–70.10) | 566.00 | 0.005d |
| Stage<br>Early stage (n=48)<br>Locally advanced and metastatic stage (n=30) | <br>17.67 (13.23–22.91)<br>21.85 (16.34–38.41) | 982.00 | 0.007d |
| Prognostic stage<br>1A (n=19)<br>1B (n=15)<br>2A (n=19)<br>2B (n=9)<br>3A (n=3)<br>3B (n=3)<br>3C (n=1)<br>4 (n=9) | <br>19.86 (17.19–28.77)<br>14.01 (8.02–24.05)*<br>19.10 (13.47–21.76)<br>18.60 (15.35–22.20)<br>21.32 (13.98–13.98)<br>14.77 (8.91–8.91)<br>34.81 (34.81–34.81)<br>40.68 (18.88–74.85) | 14.696 | 0.004c |
| Hormone Type<br>Luminal A (n=30)<br>Luminal B Her2 (-) (n=22)<br>Luminal B Her2 (+) (n=13)<br>Her2 (+) (n=6)<br>Triple negatif (n=6) | <br>17.15 (8.83–21.40)**<br>21.66 (17.03–31.77)<br>29.05 (18.86–48.04)<br>18.85 (14.25–20.06)<br>17.76 (14.37–24.96) | 16.196 | 0.003c |
| Multifocal tumor<br>Unifocal tumor (n=53)<br>Multifocal tumor (n=15) | <br>17.40 (12.95–22.44)<br>27.30 (18.60–37.94) | 585.00 | 0.006d |